This resolution expresses congressional support for continued U.S. funding and involvement with Gavi, the Vaccine Alliance, a public-private partnership that provides vaccines to children in low-income countries. Since its creation in 2000, Gavi has helped immunize over one billion children and prevented an estimated 17.3 million deaths, while reducing childhood mortality from vaccine-preventable diseases by 70 percent. The resolution highlights Gavi's cost-effectiveness, noting that vaccine programs return over $50 in health and economic benefits for every dollar invested, and emphasizes the organization's work in expanding access to new vaccines, including malaria vaccines and polio immunizations. The resolution calls on the U.S. to increase its financial commitment to Gavi during the organization's 2026 to 2030 strategic period, arguing that sustained American investment is critical for vaccine market stability, global health security, and preventing disease outbreaks that could reach American shores. While this is a non-binding resolution rather than legislation that appropriates funds or creates new programs, it signals congressional intent to prioritize U.S. support for global vaccine distribution efforts.